Sensus Healthcare, Inc. (SRTS) Income Statement
SRTS 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsSRTS revenue and net income
Where SRTS's revenue goes
2025Each bar shows an amount and its share of revenue. SRTS kept −28.1% of revenue as net income.
SRTS profit margins
SRTS growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −34.3% | −14.9% | +23.5% | +10.3% |
| Gross profit | −51.4% | −26.3% | +17.7% | +6.1% |
| Operating income | −227.4% | — | — | — |
| Net income | −216.1% | — | — | — |
| EPS (diluted) | −217.5% | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
SRTS quarterly EPS vs estimates
Sensus Healthcare beat the analyst EPS estimate in 2 of the last 8 quarters. Next report: November 5, 2026 (estimate $-0.04).
SRTS income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M | $9.6M | $27.3M | $26.4M | $20.6M | $14.8M |
| Cost of revenue | $15.6M | $17.4M | $10.3M | $14.9M | $10.1M | $4.3M | $9.7M | $9.5M | $6.8M | $5.0M |
| Gross profit | $11.9M | $24.4M | $14.1M | $29.6M | $17.0M | $5.2M | $17.6M | $16.9M | $13.8M | $9.8M |
| Research & development | $7.8M | $4.2M | $3.7M | $3.5M | $3.4M | $4.2M | $6.4M | $6.3M | $5.5M | $1.8M |
| Sales, general & admin | $14.4M | $12.1M | $10.8M | $11.3M | $9.4M | $9.3M | $13.1M | $12.7M | $12.0M | $8.4M |
| Total operating expenses | $22.2M | $16.3M | $14.4M | $14.8M | $12.9M | $13.5M | $19.5M | $18.9M | $17.5M | $10.2M |
| Operating income | −$10.3M | $8.1M | −$382,000 | $14.8M | $4.1M | −$8.2M | −$2.0M | −$2.0M | −$3.7M | −$363,119 |
| Interest income | $683,000 | $932,000 | $999,000 | $382,000 | $2,000 | $66,785 | $268,290 | $139,278 | $75,807 | $38,538 |
| Interest expense | — | — | $0 | $2,000 | $1,000 | $14,000 | $14,445 | $156,685 | $68,881 | $21,867 |
| Income before taxes | −$9.6M | $9.0M | $652,000 | $28.0M | $4.1M | −$6.8M | −$1.7M | −$2.0M | −$3.7M | −$346,448 |
| Income taxes | −$1.9M | $2.4M | $167,000 | $3.7M | −$613,000 | −$2.1M | −$545,717 | $139,278 | −$312,110 | −$299,045 |
| Net income | −$7.7M | $6.6M | $485,000 | $24.2M | $4.1M | −$6.8M | −$1.7M | −$2.0M | −$3.7M | −$346,448 |
| EBITDA | −$9.0M | $9.5M | $1.1M | $28.5M | $4.7M | −$6.1M | −$1.2M | −$1.2M | −$3.3M | $13,002 |
| EPS (diluted) | −$0.47 | $0.40 | $0.03 | $1.46 | $0.24 | −$0.50 | −$0.10 | −$0.14 | −$0.28 | −$0.03 |
| Gross margin | 43.2% | 58.4% | 57.6% | 66.5% | 62.8% | 54.8% | 64.4% | 64.0% | 67.0% | 66.5% |
| Operating margin | −37.5% | 19.4% | −1.6% | 33.3% | 15.2% | −86.0% | −7.2% | −7.6% | −18.1% | −2.5% |
| Net margin | −28.1% | 15.9% | 2.0% | 54.4% | 15.2% | −71.4% | −6.2% | −7.7% | −18.0% | −2.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3M | $3.4M | $4.9M | $6.9M | $7.3M | $8.3M | $13.1M | $8.8M | $9.2M | $10.7M | $12.6M | $3.9M |
| Cost of revenue | $1.5M | $2.4M | $3.0M | $4.2M | $4.4M | $4.0M | $6.0M | $3.6M | $3.8M | $4.0M | $4.7M | $1.9M |
| Gross profit | $769,000 | $991,000 | $1.9M | $2.7M | $2.9M | $4.4M | $7.1M | $5.2M | $5.4M | $6.7M | $7.8M | $2.0M |
| Research & development | $1.1M | $1.6M | $1.9M | $1.8M | $1.5M | $2.6M | $1.6M | $863,000 | $866,000 | $926,000 | $678,000 | $1.1M |
| Sales, general & admin | $2.8M | $3.8M | $3.2M | $3.5M | $3.4M | $4.4M | $3.8M | $2.9M | $2.6M | $2.8M | $1.6M | $2.8M |
| Total operating expenses | $3.9M | $5.3M | $5.0M | $5.3M | $4.8M | $7.0M | $5.4M | $3.7M | $3.4M | $3.8M | $2.3M | $3.9M |
| Operating income | −$3.2M | −$4.4M | −$3.1M | −$2.6M | −$1.9M | −$2.6M | $1.7M | $1.5M | $2.0M | $2.9M | $5.6M | −$1.9M |
| Interest income | $117,000 | $125,000 | $155,000 | $160,000 | $183,000 | $184,000 | $230,000 | $279,000 | $209,000 | $214,000 | $228,000 | $277,000 |
| Interest expense | — | — | — | — | — | — | — | — | — | — | $243,000 | $0 |
| Income before taxes | −$3.1M | −$4.2M | −$3.0M | −$2.4M | −$1.8M | −$2.5M | $2.0M | $1.8M | $2.2M | $3.1M | $5.8M | −$1.6M |
| Income taxes | $5.7M | −$1.6M | $174,000 | −$1.5M | −$723,000 | $110,000 | $410,000 | $559,000 | $579,000 | $827,000 | $1.6M | −$125,000 |
| Net income | −$8.7M | −$2.6M | −$3.2M | −$943,000 | −$1.0M | −$2.6M | $1.5M | $1.2M | $1.6M | $2.3M | $4.2M | −$1.5M |
| EBITDA | −$3.0M | −$4.1M | −$2.8M | $681,999 | −$1.6M | −$2.3M | $2.1M | $1.9M | $2.3M | $3.2M | $5.9M | −$1.5M |
| EPS (diluted) | −$0.18 | −$0.16 | −$0.19 | −$0.06 | −$0.06 | −$0.16 | $0.09 | $0.07 | $0.10 | $0.14 | $0.26 | −$0.09 |
| Gross margin | 33.6% | 29.2% | 38.4% | 39.4% | 39.7% | 52.2% | 54.4% | 59.3% | 58.7% | 62.5% | 62.3% | 51.0% |
| Operating margin | −138.9% | −128.4% | −63.8% | −37.3% | −26.6% | −31.7% | 13.2% | 16.9% | 21.5% | 27.1% | 44.4% | −48.6% |
| Net margin | −382.1% | −77.4% | −64.1% | −13.7% | −14.2% | −30.8% | 11.8% | 13.7% | 17.4% | 21.3% | 33.5% | −37.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SRTS's financial statements (latest annual report filed March 4, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
SRTS financial results
In fiscal year 2025 (ended December 31, 2025), Sensus Healthcare reported revenue of $27.5 million, down 34.3% from the year before. It had a net loss of $7.7 million, a net profit margin of −28.1%. Diluted earnings per share came to −$0.47. Over five years revenue grew at an average rate of 23.5% a year.
See the SRTS stock overview for the latest quote and news, or the SRTS chart for price history and technical indicators.
SRTS income statement FAQ
What is Sensus Healthcare's annual revenue?
Sensus Healthcare reported total revenue of $27.5 million for fiscal year 2025, which ended on December 31, 2025. That was down 34.3% from $41.8 million the previous year.
Is Sensus Healthcare profitable?
No. Sensus Healthcare reported a net loss of $7.7 million in fiscal 2025, a net profit margin of −28.1%; its operating margin was −37.5%.
What is Sensus Healthcare's gross margin?
Sensus Healthcare's gross margin was 43.2% in fiscal 2025: for every $100 of revenue, Sensus Healthcare kept $43 after the direct cost of its products and services.
How much does Sensus Healthcare spend on research and development?
Sensus Healthcare spent $7.8 million on research and development in fiscal 2025, 28.3% of revenue.
How fast is Sensus Healthcare growing?
Revenue grew 23.5% a year on average over the last five fiscal years, from $9.6 million to $27.5 million.
What are Sensus Healthcare's earnings per share?
Sensus Healthcare earned $-0.47 per diluted share in fiscal 2025, compared with $0.40 a year earlier.
When will Sensus Healthcare report its next earnings?
Sensus Healthcare is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes.
When does Sensus Healthcare's fiscal year end?
Sensus Healthcare's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 4, 2026.